Dr. Shpall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1983 - 1985
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1980 - 1983
- University of Cincinnati College of MedicineClass of 1980
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2025
- TX State Medical License 2002 - 2025
- GA State Medical License 2023 - 2024
- TN State Medical License 2023 - 2024
- LA State Medical License 2023 - 2024
- AL State Medical License 2023 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes Start of enrollment: 2001 Feb 01
- Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor Start of enrollment: 2006 Sep 01
- Cord Blood Expansion on Mesenchymal Stem Cells Start of enrollment: 2007 Jul 03
- Join now to see all
Publications & Presentations
PubMed
- Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.Sairah Ahmed, Qaiser Bashir, Roland L Bassett Jr, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa Khouri, David Marin, ...> ;American Journal of Hematology. 2024 Apr 1
- Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome.Pille, M., Avila, J., Park, S., Le, C., Xue, H., Haerynck, F., Saxena, L., Lee, C., Bao, G., Vandekerckhove, B., Davis, B., Shpall, E.> ;Molecular Therapy. Methods & Clinical Development. 2024 Mar 14
- Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.Curtis Marcoux, Rima M Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday Popat, Betul Oran, Amanda Olson, Qaiser Bashir, Mu...> ;Blood Advances. 2024 Mar 12
- Join now to see all
Journal Articles
- The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant RecipientsRoy F Chemaly, Elizabeth Shpall, The Journal of Infectious Diseases
- Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell TherapyKris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
Abstracts/Posters
- Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 OverexpressionElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical TrialElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell TransplantationElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Assessment and Management of Cytokine Release SyndromeASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Top Keywords at TCT in 'Virtual' HawaiiFebruary 16th, 2021
- Genetically Enhanced, Cord-Blood Derived Immune Cells Strike B-cell CancersOctober 23rd, 2020
- Cell Therapy Ascends: New Hope for Combating Mantle Cell LymphomaOctober 20th, 2020
- Join now to see all
Grant Support
- Hematopoietic Progenitor Cells - Cord BloodNational Cancer Institute2010–2012
- Improving Cord Blood TransplantationNational Cancer Institute2011
- GOOD Manufacturing Practice (GMP) And Immune Assessment CoreNational Cancer Institute2010–2011
- Hematopoietic Progenitor CellsNational Cancer Institute2002–2007
- Hematopoietic Progenitor CellsNational Cancer Institute1993–2002
- Detection Of Malignant Cells In Marrow &Pbpc FractionsNational Cancer Institute1998–1999
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: